Theodor Leber

From WikiMD's WELLNESSPEDIA

TheodorLeber

Theodor Leber (29 February 1840 – 17 April 1917) was a German ophthalmologist known for his contributions to the field of ophthalmology. He is best known for his research on various eye diseases, including Leber's congenital amaurosis and Leber's hereditary optic neuropathy.

Early Life and Education[edit]

Theodor Leber was born in Karlsruhe, Grand Duchy of Baden. He studied medicine at the University of Heidelberg, where he was influenced by the work of Hermann von Helmholtz. Leber completed his medical degree in 1862 and subsequently worked as an assistant to Albrecht von Graefe in Berlin.

Career[edit]

Leber's career was marked by significant contributions to the understanding of eye diseases. He held various academic positions, including a professorship at the University of Göttingen. His research primarily focused on the pathology of the eye, and he made groundbreaking discoveries in the field.

Leber's Congenital Amaurosis[edit]

Leber's congenital amaurosis (LCA) is a rare genetic eye disorder that leads to severe vision loss at birth. Leber was the first to describe this condition, which is now known to be caused by mutations in several different genes.

Leber's Hereditary Optic Neuropathy[edit]

Leber's hereditary optic neuropathy (LHON) is another condition named after Theodor Leber. It is a mitochondrial genetic disorder that leads to the degeneration of retinal ganglion cells and subsequent loss of central vision.

Legacy[edit]

Theodor Leber's work has had a lasting impact on the field of ophthalmology. His research laid the foundation for further studies on genetic eye diseases and their treatments. Leber's name continues to be associated with the conditions he first described, and his contributions are still recognized in modern medical literature.

Related Pages[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.